For: | Yang HY, Du YX, Hou YJ, Lu DR, Xue P. Hyperprogression after anti-programmed death-1 therapy in a patient with urothelial bladder carcinoma: A case report. World J Clin Cases 2023; 11(28): 6841-6849 [PMID: 37901032 DOI: 10.12998/wjcc.v11.i28.6841] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v11/i28/6841.htm |
Number | Citing Articles |
1 |
Juyan Ge, Xiujuan Xu. The Expression of Programmed Cell Death Ligand-1 and its Relationship with Infiltration, Metastasis and Prognosis in Cervical Squamous Cell Carcinoma. Reproductive Sciences 2025; doi: 10.1007/s43032-024-01784-5
|
2 |
|
3 |
Shenrui Guo, Zhen Tan, Wenbin Guan, Yafu Yin. Early Hyperprogression of Rhabdomyosarcoma Detected by 18F-FDG PET/CT Three Weeks after CAR-T Treatment. World Journal of Nuclear Medicine 2024; 23(03): 212 doi: 10.1055/s-0044-1787537
|